• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPACEOAR SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPACEOAR SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SO-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Fever (1858); Fistula (1862); Unspecified Infection (1930); Pain (1994); Sepsis (2067); Ulcer (2274); Swelling/ Edema (4577)
Event Date 04/21/2022
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that spaceoar was implanted during a spaceoar placement procedure performed on an unknown date.Fiducial markers were placed during the same procedure.The patient received four treatments of standard fractionated intensity-modulated radiation therapy (imrt) a few weeks after the spaceoar procedure.The patient started complaining of pain in the abdominal area, swelling in the groin and testicular areas.The patient had multiple emergency room (er) visits and was diagnosed as septic.The physician evaluated the patient and was able to locate a large fistula starting in the rectum, through the prostate and into the bladder.The patient was treated with a permanent colostomy and was advised to undergo a colonoscopy.The patient was admitted to a hospital beyond the standard of care.The patient's outcome was reported to be disability and permanent damage.Boston scientific has been unable to obtain additional information regarding the event to date, despite good faith efforts.
 
Manufacturer Narrative
The exact date of the event is unknown.The provided event date, (b)(6) 2022, was chosen as a best estimate based on the date that the manufacturer became aware of the event, 17jun2022.The complainant was unable to provide the suspect device lot number.Therefore, the manufacture date and expiration date are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that spaceoar was implanted during a spaceoar placement procedure performed on an unknown date.Fiducial markers were placed during the same procedure.The patient received four treatments of standard fractionated intensity-modulated radiation therapy (imrt) a few weeks after the spaceoar procedure.The patient started complaining of pain in the abdominal area, swelling in the groin and testicular areas.The patient had multiple emergency room (er) visits and was diagnosed as septic.The physician evaluated the patient and was able to locate a large fistula starting in the rectum, through the prostate and into the bladder.The patient was treated with a permanent colostomy and was advised to undergo a colonoscopy.The patient was admitted to a hospital beyond the standard of care.The patient's outcome was reported to be disability and permanent damage.**additional information received on august 2, 2022.It was reported to boston scientific corporation that spaceoar was implanted during a spaceoar placement procedure performed on (b)(6) 2022.The patient received four treatments of standard fractionated intensity-modulated radiation therapy (imrt) that started on (b)(6) 2022 and ended on (b)(6) 2022.For the last treatment, the patient complained about the pain he experienced in his scrotum.The physician review the cone-beam computed tomography systems (cbct) and found out that there was air in the patients bladder.The pain was predominately on the left side, when visually inspected it was inflamed and sensitive to touch.Physician advised the patient to go to the emergency room and was determined that the patient had an infection with fluid surrounding the left testicle and was sent home with antibiotics.The following week the pain had not subsided and the patient was re-admitted to the emergency room where it was determined the infection was septic.On (b)(6) 2022 the fluid was drained from his testicles and a rectal exam was performed.The colorectal surgeon felt a hole in the rectum that went through the prostate and into the bladder.Patient was scoped and the bladder was filled with cloudy urine and a fistula was confirmed.On (b)(6) 2022 a non reversible laparoscopic colonostomy was performed and a heavy course of antibiotics was prescribed.The patient was admitted to a hospital for three weeks before being discharged.The physician advised that there will be no longer additional radiation and to continue the hormone therapy.The physician said that there are no obvious signs that the gel was misplaced, it appears to be in the appropriate location.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture date and expiration date are unknown.Block h2: blocks a: patient information, b3, b5, b7 and d6a have been updated with the additional information received on august 2, 2022.Block h6: clinical code e2314 captures the reportable event of fistula.Clinical code e2339 captures the reportable event of ulcer.Clinical code e2330 captures the reportable event of pain.Clinical code e0306 captures the reportable event of sepsis.Clinical code e2326 captures the reportable event of unspecified infection.Evaluation conclusion code d17 is being used in lieu of an adequate conclusion code for "device not returned".Block h10: the complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.Block h11: correction to field d4: unique identifier.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15100016
MDR Text Key296562197
Report Number3005099803-2022-03945
Device Sequence Number1
Product Code OVB
UDI-Device Identifier00864661000102
UDI-Public00864661000102
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSO-2101
Device Catalogue NumberSO-2101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other;
Patient Age72 YR
Patient SexMale
Patient RaceBlack Or African American
-
-